Skin Cancer Surgery Insurance Denied? How to Appeal

A skin cancer diagnosis is frightening enough on its own. Receiving an insurance denial for the surgery your physician recommended adds financial stress and urgency that no patient should have to face. Yet denials for skin cancer procedures — including Mohs micrographic surgery, wide local excision, sentinel lymph node biopsy, and post-surgical reconstruction — occur regularly across every major insurer. If your skin cancer surgery has been denied, you have strong grounds to appeal, and acting quickly matters.

Why Insurers Deny Skin Cancer Surgery

Skin cancer surgery denials follow consistent patterns tied to procedure type, tumor characteristics, and documentation quality.

Mohs surgery deemed inappropriate for tumor type or location. Mohs micrographic surgery (CPT 17311–17315) is the gold standard treatment for basal cell carcinoma (C44.xx1) and squamous cell carcinoma (C44.xx2) at high-risk anatomic locations, with cure rates of 98–99% for BCC and 95–97% for SCC. Insurers apply the American Academy of Dermatology (AAD) and American College of Mohs Surgery (ACMS) Appropriate Use Criteria (AUC) — published in JAAD 2012;67:531-550 — to evaluate Mohs coverage. A denial claiming the tumor's type, size, or location did not meet AUC criteria should be directly countered with the pathology report and the specific AUC criteria that apply to your tumor.

Reconstruction classified as cosmetic. After skin cancer removal — particularly on the face, ears, eyelids, nose, and scalp — the resulting surgical defect requires repair. Reconstruction procedures (CPT 14000–14350 for adjacent tissue transfer; 15000–15278 for skin grafts; CPT 67950 for eyelid reconstruction) are sometimes denied as "cosmetic" even when the defect was directly caused by cancer removal surgery. Reconstruction necessitated by cancer surgery is medically necessary, not cosmetic — the cosmetic exclusion applies to procedures performed for appearance without medical need, not to reconstructing tissue lost in cancer treatment.

Wide local excision documentation incomplete. Standard wide local excision (CPT 11600–11646) for malignant skin lesions requires a confirmed histologic diagnosis and accurate coding by lesion size and location. If the claim lacks a confirmed malignant biopsy result, an accurate ICD-10 diagnosis code, or the specific CPT code matching the excised diameter, the insurer may deny on documentation grounds.

Sentinel lymph node biopsy denied based on staging criteria. For melanoma (C43.xx), sentinel lymph node biopsy (SLNB, CPT 38792 + 38900) is recommended by NCCN guidelines (NCCN Clinical Practice Guidelines in Oncology: Melanoma, v.3.2025) for T1b melanomas (≥0.8 mm Breslow thickness or ulcerated) and T2–T4 melanomas. Denials for SLNB typically cite staging criteria — if the insurer's reviewer applies more restrictive staging thresholds than NCCN recommends, this is the basis for an evidence-based appeal.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained. Some plans require prior authorization for Mohs surgery, SLNB, or major skin cancer procedures. Retroactive denials for missing prior authorization can sometimes be overturned by demonstrating that the procedure was performed in an urgent or time-sensitive context that precluded advance authorization.

How to Appeal a Skin Cancer Surgery Denial

Step 1: Obtain the denial letter and identify the specific denial basis

Request the complete written denial specifying the clinical criteria applied, the policy provision cited, and the specific reason for denial. This document determines the entire strategy for your appeal. Different denial bases (cosmetic exclusion, AUC criteria, SLNB staging, prior authorization) require fundamentally different responses.

Step 2: Verify accurate ICD-10 and CPT coding on the claim

Confirm that the histologic diagnosis is correctly coded: C44.01x–C44.99x for skin cancer by location, C43.xx for melanoma, with the fourth and fifth character specifying the subtype and laterality. Confirm that the CPT code matches the specific procedure performed and the excised diameter or stage count. For reconstruction, confirm that the reconstruction codes are linked to the primary cancer procedure.

Step 3: Obtain the pathology report and the surgeon's letter of medical necessity

The biopsy pathology report is the cornerstone document establishing that surgery was performed for a confirmed malignancy, not electively. Your surgeon — dermatologic surgeon, Mohs surgeon, or plastic surgeon — should write a detailed letter of medical necessity documenting: the tumor diagnosis and characteristics, why the specific procedure was selected over alternatives, the applicable AAD/ACMS AUC criteria (for Mohs), the NCCN staging criteria (for melanoma SLNB), and why any reconstruction was necessitated by the cancer surgery rather than performed for cosmetic reasons.

Step 4: Address the cosmetic exclusion argument directly

If the denial characterizes reconstruction as cosmetic, your appeal letter must explicitly counter this characterization. Include documentation showing that: the reconstruction was performed on the same operative encounter as the cancer surgery, the defect was directly created by the cancer excision, the reconstruction was performed to restore function or protect vital structures (eyelid function, nasal patency, oral competence), and there was no separate cosmetic indication documented.

Step 5: Submit the internal appeal within the deadline

Most plans require internal appeals within 180 days of the denial. File in writing with all supporting documentation. Include your appeal letter addressing the specific denial basis, the pathology report, the surgeon's letter of medical necessity citing AAD/ACMS AUC or NCCN guidelines as applicable, and corrected coding documentation if needed.

Step 6: Request external independent review if the internal appeal fails

External reviewers apply objective clinical standards rather than the insurer's proprietary criteria. For confirmed skin cancer surgery denials — particularly Mohs for high-risk tumors and reconstruction necessitated by cancer surgery — external reversal rates are meaningful when the clinical documentation is complete.

What to Include in Your Appeal

• Written denial letter with the specific clinical criteria or policy provision cited
• Biopsy pathology report confirming the histologic diagnosis, tumor type, subtype, and date
• Surgeon's letter of medical necessity citing AAD/ACMS AUC (for Mohs) or NCCN guidelines (for melanoma), with specific reference to your tumor characteristics
• Documentation that any reconstruction was performed due to the cancer surgical defect, not for cosmetic purposes
• Accurate ICD-10 codes (C44.xx, C43.xx) and CPT codes confirmed on the claim

Fight Back With ClaimBack

Skin cancer surgery denials based on cosmetic classification or insufficient AUC criteria directly contradict established clinical standards from the AAD, ACMS, and NCCN. When the pathology report documents a confirmed malignancy and the surgery meets established clinical criteria, a well-constructed appeal citing those guidelines has strong grounds for reversal. ClaimBack helps you build a targeted appeal for your skin cancer surgery denial in minutes. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal